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Abstract
Purpose:  Warthin’s  tumor  is  the  second  most  frequent  benign  tumor  of  the  parotid  gland,  with  no
risk of  malignant  evolution.  That  is  why  surgery  should  be  avoided  if  the  preoperative  diagnosis
is certain.  The  aim  of  the  study  was  to  assess  the  added  value  of  a  decisional  algorithm  for  the
preoperative  diagnosis  of  Warthin’s  tumor.
Materials  and  methods:  This  retrospective  IRB-approved  study  included  75  patients  who  under-
went standardised  MRI  with  conventional  sequences  (T1-  and  T2-weighted  images,  and  T1
post-contrast  sequences  with  fat  saturation)  and  functional  sequences:  diffusion  (b0,  b1000)
and perfusion  MR.  Two  independent  readers  reviewed  the  images  using  the  decisional  algo-
rithm. The  conclusion  of  each  reader  was:  the  lesion  is  or  is  not  a  Warthin’s  tumor.  The  MRI
conclusion  was  compared  with  histology  or  with  cytology  and  follow-up.  We  calculated  the
Cohen’s kappa  coefﬁcient  between  the  two  observers  and  the  sensitivity  and  speciﬁcity  of  the
algorithm-helped-reading  for  the  diagnosis  of  Warthin’s  tumor.
Results:  Seventy-ﬁve  patients;  histology  (n  =  61)  or  cytology  and  follow-up  (n  =  14)  results
revealed 20  Warthin’s  tumors  and  55  other  tumors.  Using  the  algorithm,  sensitivity  and  speci-
ﬁcity were  80—96%,  and  85—100%,  respectively  for  readers  1  and  2.  The  Cohen’s  kappa
coefﬁcient  between  the  two  observers  was  0.79  (P  <  0.05)  for  the  diagnosis  of  Warthin’s  tumor.
Conclusion:  Our  decisional  algorithm  helps  the  preoperative  diagnosis  of  Warthin’s  tumor.  The
speciﬁcity of  the  technique  is  sufﬁcient  to  avoid  surgery  if  a  parotid  gland  tumor  presents  all Wartthe MRI  characteristics  of  a
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Warthin’s  tumor  is  the  second  most  frequent  benign
umor  of  the  parotid  gland  (the  ﬁrst  one  is  pleomorphic
denoma)  [1].  This  parotidian  tumor  occurs  most  often  in
mokers  [2],  in  middle-aged  and  older  men  [3].  It  is  usually
ocated  at  the  inferior  pole  of  the  gland  and  multicentric
ccurrence  is  seen  more  often  with  Warthin’s  tumor  than
ith  any  other  salivary  gland  tumor  [4].  Unlike  pleomor-
hic  adenomas,  Warthin’s  tumor  presents  less  than  1%  risk
f  malignant  evolution  [5].  That  is  why  surgery  is  not  neces-
ary  when  the  preoperative  diagnosis  is  certain  and  surgery
hould  be  avoided  as  often  as  possible  because  of  the  risk  of
acial  nerve  injury  during  surgery  [6,7].
In  this  clinical  context,  when  faced  to  a  parotid  gland
umor,  MRI  [8—12]  and  ﬁne  needle  aspiration  cytology
FNAC)  are  widely  used  before  surgery  [6,13]. FNAC  is  the
ost  cost  effective  and  minimally  invasive  way  to  deter-
ine  the  histological  character  of  a  parotid  gland  tumor.
ut,  it  is  not  always  conclusive  because  the  material  may  be
nsufﬁcient.  Furthermore,  in  case  of  Warthin’s  tumor,  which
ontains  inﬂammatory  cells,  FNAC  can  be  responsible  for
n  inﬂammatory  ﬂare  with  pain  and  volume  increase  of  the
esion  [14].  On  the  other  hand,  MRI  accuracy  for  the  diagno-
is  of  Warthin’s  tumor  has  never  been  clearly  reported,  since
n  most  studies,  the  aim  was  to  distinguish  the  difference
etween  malignant  and  benign  lesions,  pooling  pleomor-
hic  adenomas  and  Warthin’s  tumors  [8—12].  As  far  as  we
now,  there  is  only  one  study  about  Warthin’s  tumor  and
ts  MR  diagnosis  value  [15],  but  the  sensitivity  and  speci-
city  of  the  technique  are  not  reported  in  this  study.  That
s  why  most  surgeons  are  still  going  on  surgical  treatment
or  these  benign  tumors,  despite  of  the  risk  of  facial  palsy
16].  Furthermore,  to  our  knowledge,  all  the  MR  imaging
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igure 1. Flowchart shows patient population. Only the ﬁrst complet
NAC: ﬁne needle cytology aspiration.S.  Espinoza  et  al.
tudies  tested  the  interest  of  anatomical  sequences  and/or
unctional  sequences  [8—12], but  no  study  tested  the  inter-
st  of  the  whole  examination,  including  all  the  available
R  imaging  data,  it  means:  morphology,  signal,  diffusion
ith  apparent  diffusion  coefﬁcient  (ADC)  map,  and  dynamic
ontrast-enhanced  MR  imaging  with  time—intensity  curve
attern,  in  order  to  establish  the  value  of  MR  imaging  for  the
iagnosis  of  Warthin’s  tumor.  We  have  published  a decisional
lgorithm  for  the  interpretation  of  parotid  gland  tumor  MR
maging,  taking  into  account  all  the  MRI  data,  including  func-
ional  data  [17].
The  aim  of  the  study  was  to  assess  the  added  value  of
ur  decisional  algorithm  for  the  preoperative  diagnosis  of
arthin’s  tumor.
ethods and materials
atients
etween  January  2006  and  December  2012,  our  MR  imag-
ng  database  was  retrospectively  queried  to  identify  all
atients  who  underwent  contrast-enhanced  MR  imaging  of
arotid  gland  (n  =  1039).  Patients  with  no  parotid  gland
bnormality  (n  =  901;  most  often  these  MR  examinations
orresponded  to  MR  follow-up  after  surgery),  with  inﬂam-
atory  disease  (n  =  6)  or  with  incomplete  MR  imaging  (n  = 8)
here  excluded.  Mainly  cystic  lesions  (n  =  3)  were  excluded
ecause  it  was  not  possible  to  place  a  region  of  interest  in
 tissular  part,  and  then  diffusion  and  perfusion  sequences
ould  not  be  analysed.  Lesions  less  than  10  mm  in  diam-
ter  were  excluded  (n  =  2)  because  they  corresponded  to
e MR imaging was selected. The ﬁnal cohort included 75 patients.
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Table  1  Acquisition  protocol.
Sequence
Parameter  Transverse
T1-
weighted
FSE
sequence
Transverse
T2-
weighted
FR  FSE
sequence
Coronal  T2-
weighted
FR  FSE
sequence
Transverse
Diffusion
weighted
sequence
Perfusion
Sequence
Transverse
T1-
weighted
post
Gadolinium
with  Fat
saturation
Coronal  T1-
weighted
post
Gadolinium
with  Fat
saturation
Repetition  time
(ms)
650  5350  3924  8000  7.4  488  519
Echo  time  (ms) 11.8  110  110  Min  2.16  Min  full  Min  full
Echo  train  length  2  16  16  —  —  4  3
Section  thickness
(mm)
4 4  4  5  4  4  4
Intersection  gap
(mm)
0.4  0.4  0.4  0  0  0.4  0.4
Field  of  view
(mm)
180  240  180  280  280  170  190
Matrix  256  ×  224 384  ×  256 320  ×  224  96  ×  128  192  ×  192  288  ×  224  288  ×  224
No  of  signals
acquired
2  3  3  2  0.5  2  1
Bandwith  (hHz)  31.25  41.67  31.25  250  25  31.25  19.23
Nb  slices  30  33  22  30  50  28  21
Acquisition  time 148  134  173  64  180  243  125
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intra  parotid  lymph  nodes.  Patients  who  did  not  undergo  nei-
ther  surgery  nor  ﬁne  needle  aspiration  cytology  and  at  least
12  months  clinical  and  MRI  follow-up  were  excluded  (n  =  19).
For  patients  who  underwent  multiple  MR  examinations,  only
the  ﬁrst  complete  MR  imaging  was  selected  (n  =  25).  The  ﬁnal
cohort  included  75  patients  (Fig.  1).  Our  institutional  ethics
committee  approved  this  retrospective  study  and  waived  the
requirement  to  obtain  informed  consent.
MR Imaging technique
MRI  was  performed  with  a  1.5  T  Signa  HDX  MR  System  (GE
Medical  Systems,  Waukesha,  WI,  USA)  using  a  head  and
neck  phased  array  coil.  The  acquisition  protocol  (Table  1)
included  conventional  sequences  (transverse  T1-weighted
fast  spin-echo,  transverse  and  coronal  T2-weighted  FR
fast  spin-echo),  and  functional  sequences  (transverse  dif-
fusion  weighted  images  with  b  values  of  0  and  1000s/mm2,
and  dynamic  contrast-enhanced  sequence  in  the  transverse
plane,  after  gadolinium  chelate  injection  at  a  dose  of
0.2  mL/kg  via  a  power  injector  at  a  rate  of  4  mL/s,  followed
by  injection  of  20  mL  of  normal  saline  to  ﬂush  the  tubing;
images  were  obtained  at  a  3.6  s  interval  for  180  s).  Finally,
transverse  and  coronal  T1-weighted  fast  spin-echo  images
with  fat  saturation  were  systematically  acquired  after  injec-
tion  of  the  gadolinium  chelate.MR image analysis
All  exams  were  transferred  to  a  workstation  (ADW  4.2,  GE
Healthcare)  and  anonymized.
a
w
cTwo  different  radiologists  with  respectively  6  months  and
 years  of  experience  in  head  and  neck  imaging,  indepen-
ently  reviewed  the  images.  Observers  were  blinded  to  MR
maging  reports,  clinical  history,  and  results  of  pathologic
xamination.
Tumor  side  and  size  were  recorded.  Tumor  margins  were
ualiﬁed:  well  deﬁned  tumor,  lobulated  tumor  or  irregular
argins.
ignal  analysis
n  T1-weighted  images,  the  signal  intensity  of  the  lesion
as  compared  with  the  signal  of  the  normal  parotid  gland
arenchyma:  low  signal,  iso-signal  or  high  signal.  We  noted
he  homogeneous  or  heterogeneous  character  of  the  lesion.
f  high  signal  areas  were  present,  we  recorded  the  size  of
he  high  signal  intensity  zone:  small  spot  or  large  area.  On
2-weighted  images,  the  signal  of  the  lesion  was  compared
ith  the  signal  of  the  normal  parenchyma  and  with  the  signal
f  the  cerebrospinal  ﬂuid  on  the  posterior  fossa:  if  the  lesion
ignal  was  lower  than  normal  gland  parenchyma,  the  tumor
ignal  was  qualiﬁed  as  low  signal;  if  the  tumor  signal  was  as
igh  as  the  cerebrospinal  ﬂuid,  it  was  qualiﬁed  as  high  signal.
etween  these  two  categories,  it  was  qualiﬁed  as  intermedi-
ry  signal.  The  cystic  component  was  deﬁned  as  a  tissue  that
howed  high  T1  signal  intensity  and/or  did  not  enhance  nei-
her  on  perfusion  sequence  nor  on  late  post-contrast  images.
y  deﬁnition,  the  solid  component  showed  enhancement
fter  injection,  on  perfusion  or  late  post-contrast  images.
The  DW  images  were  analysed  with  the  Functool  Soft-
are  (9.3.02e,  GE  Healthcare).  On  the  apparent  diffusion
oefﬁcient  (ADC)  map,  2  regions  of  interest  (ROI)  measuring
4 S.  Espinoza  et  al.
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Table  2  Two  by  2  diagnostic  table  for  reader  1.
Histology
Reader  1  Warthin’s
tumor
Other
tumor
Totals
Warthin’s  tumor  16  2  18
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Discussion
This  study  showed  the  value,  for  the  diagnosis  of  Warthin’s
tumor,  of  our  decisional  algorithm,  taking  into  account  all
Table  3  Two  by  2  diagnostic  table  for  reader  2.
Histology
Reader  2  Warthin’s
tumor
Other
tumor
Totals0  
 to  5  mm  in  diameter  were  placed:  the  ﬁrst  one  in  the  solid
omponent  of  the  tumor  and  the  second  one  in  the  normal
ontralateral  gland.  The  ratio  between  the  tumor  ADC  and
he  normal  gland  ADC  was  recorded.
The  dynamic  enhancement  pattern  was  evaluated
ccording  to  the  Yabuuchi  study  [8]  after  positioning  a  4
o  5  mm  diameter  region  of  interest  in  the  solid  part  of  the
umor:  type  A  time—intensity  curve  corresponded  to  a  grad-
al  increase  in  the  signal  intensity,  with  a  peak  time  longer
han  120  s;  in  type  B  curve,  time  to  peak  was  shorter  than
r  equal  to  120  s  and  the  washout  ratio  [deﬁned  as  follows:
SI  max  —  SI  3  min)/(SI  max  —  SI  pre)  ×  100]  was  greater  than
r  equal  to  30%;  in  type  C  curve,  time  to  peak  was  shorter
han  or  equal  to  120  s  and  the  washout  ratio  was  less  than
0%.  The  only  modiﬁcation  to  the  Yabuuchi  protocol  was  a
 min  time  sampling  in  our  study  compared  with  a  5  min  time
ampling  in  his  study.
esion characterization
umors  with  irregular  margins  were  considered  as  malig-
ant  tumors,  and  the  algorithm  was  not  used.  For  the  other
umors,  MR  images  were  analysed  according  to  our  algo-
ithm  (Fig.  2).  Both  readers  characterized  the  lesions  as
arthin’s  tumors  or  other  diagnoses  (pleomorphic  adeno-
as  and  malignant  tumors  were  pooled).  For  both  readers,
nd  for  each  MR  data  set,  the  time  necessary  for  the  analysis
as  recorded.
tatistical analysis
e  presented  results  according  to  the  STARD  statement  rec-
mmendations  [18].
The  surgical  pathologic  ﬁndings  (given  by  a  pathologist
ith  15  years  of  experience  in  parotid  gland  tumors  analy-
is)  were  used  as  the  reference  standard  for  the  assessment
f  parotid  tumors.  For  non-surgically-treated  tumors,  cytol-
gy  (performed  by  a  pathologist  with  a  23-year  experience
n  parotid  gland  tumors  cytology)  associated  with  a  one-
ear  clinical  and  MRI  follow-up  were  used  as  the  reference
tandard.
For  both  readers,  sensitivity,  speciﬁcity,  accuracy,  posi-
ive  and  negative  likelihood  ratios,  and  positive  and  negative
redictive  values  for  the  diagnosis  of  Warthin’s  tumor  were
alculated.  The  95%  conﬁdence  intervals  were  calculated
ccording  to  the  efﬁcient-score  method  described  by  New-
ombe  [19].  To  assess  between  radiologists  agreement,  we
sed  the  Cohen’s  kappa  coefﬁcient.
esults
opulation
e  included  75  patients  (33  women,  42  men)  with  a  mean
ge  of  52.1  years.  Tumors  were  located  in  the  right  parotid
land  for  44  patients  and  in  the  left  parotid  gland  for  31
atients.
Histological  results  were  obtained  for  61  patients;  the
4  remaining  patients  underwent  ﬁne  needle  cytology  aspi-
ation  and  at  least  one-year  clinical  and  MRI  follow-up.
mong  the  75  tumors,  20  were  Warthin’s  tumors,  39  wereOther  tumor  4  53  57
Totals 20  55  75
leomorphic  adenomas,  13  were  malignant  tumors  and  3
ere  other  benign  tumors  (1  oncocytoma,  1  basal  cell  ade-
oma,  1  myoepithelioma).
RI results
he  mean  time  required  for  analysis  of  one  data  set  for
eaders  1 and  2  was  6.1  min  and  5.7  min,  respectively.  The
ohen’s  kappa  coefﬁcient  between  the  two  observers  was
.79  (P  <  0.05)  for  the  diagnosis  of  Warthin’s  tumor.
The  2  by  2  diagnostic  tables  for  each  reader  are  shown
n  Tables  2  and  3. The  accuracy  of  the  technique  for  the
iagnosis  of  Warthin’s  tumor  was  92%  and  96%  respectively,
or  readers  1  and  2.
For  the  ﬁrst  reader,  sensitivity  and  speciﬁcity  of  the
echnique  for  the  diagnosis  of  Warthin’s  tumor  were  respec-
ively:  80.0%  (95%  CI:  55.7%—93.3%)  and  96.4%  (95%  CI:
6.4%—99.4%).  There  were  2  false  positive  results  of
arthin’s  tumor:  one  low  grade  malignant  tumor  and  one
asal  cell  adenoma.  Positive  and  negative  likelihood  ratios
ere  respectively  22.0  (95%  CI:  5.5—87.2)  and  0.2  (95%  CI:
.1—0.5).
For  the  second  reader,  sensitivity  and  speciﬁcity  of  the
echnique  for  the  diagnosis  of  Warhtin’s  tumor  were  respec-
ively:  85.0%  (95%  CI:  61.1%—96.0%)  and  100%  (95%  CI:
1.9%—100%).  There  was  no  false  positive  result.  Positive
nd  negative  likelihood  ratios  were  respectively  not  com-
utable  and  0.15  (95%  CI:  0.05—0.43).
In  our  population,  where  the  prevalence  of  Warthin’s
umor  was  26.7%,  positive  and  negative  predictive  values
ere  respectively  88.9%  (95%  CI:  63.9%—98.1%)  and  93.0%
95%  CI:  82.2%—97.7%)  for  reader  1  and  100%  (95%  CI:
7.1%—100%)  and  94.8%  (95%  CI:  84.7%—98.7%)  for  reader
.Warthin’s  tumor  17  0  17
Other  tumor  3  55  58
Totals  20  55  75
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fFigure 2. Algorithm used for MRI interpretation. Lesions less than
irregular margins were not classiﬁed with this algorithm.
the  available  MR  data,  including  morphological,  signal  and
functional  data:  the  time  of  analysis  for  each  data  set  is
very  reasonable;  there  is  a  good  inter  observers  correlation,
allowing  to  radiologists  with  few  experience  in  head  and
neck  imaging  to  achieve  a  very  satisfactory  speciﬁcity  for  the
diagnosis  of  Warthin’s  tumor,  very  similar  to  the  speciﬁcity
of  an  experienced  radiologist.
The  very  high  speciﬁcity  of  this  technique  (96—100%)  is
very  interesting  because  if  the  MR  ﬁndings,  according  to
our  algorithm,  are  typical  of  a  Warthin’s  tumor,  the  risk  of
error  is  very  low,  less  than  4%.  That  means  that  the  risk
of  avoiding  a  necessary  surgery  (for  a  malignant  tumor  or
for  a  pleomorphic  adenoma)  is  very  low.  This  risk  has  to  be
compared  with  the  risk  of  surgical  complication:  the  most
feared  surgical  complication  is  facial  nerve  injury  with  facial
palsy.  Most  often,  it  is  transient  palsy,  which  is  reported  in
8—24%  cases  [20].  But  it  can  also  be  permanent  facial  palsy,
which  is  reported  in  2—3%  cases  [21].  The  high  speciﬁcity
of  the  technique  for  the  preoperative  diagnosis  of  Warthin’s
tumor  means  that  there  is  a  very  low  risk  of  false  positive
of  diagnosis  of  Warthin’s  tumor.  That  is  why  we  think  that
non-operative  management  of  Warthin’s  tumors,  when  MRI
ﬁndings  are  typical  according  to  our  algorithm,  is  a  satisfac-
tory  option.
Reader  1  had  2  false  positive  results.  The  ﬁrst  one  was  a
low  grade  malignant  tumor,  with  no  high  T1  intensity  zone,
with  an  ADC  ratio  =  1.1.  On  the  perfusion  sequence,  the
washout  ratio  measured  by  reader  1  was  32%.  For  reader
2,  the  washout  ratio  was  29%.  This  difference  was  due
to  the  ROI  position.  The  second  false  positive  result  of
reader  1  was  a  basal  cell  adenoma.  It  presented  a  large
high  T1  intensity  zone.  ADC  ratio  was  1.1.  On  the  perfusion
sequence,  the  washout  ratio  measured  by  reader  1  was  30%.
t
p
w in diameter and mainly cystic lesions were excluded. Lesions with
or  reader  2,  the  washout  ratio  was  26%.  This  difference
as  also  due  to  the  ROI  position.  Furthermore,  unlike  typ-
cal  Warthin’s  tumors  according  to  Yabuuchi  study,  for  both
esions,  time—intensity  curves  presented  for  both  readers
 low  decreasing  slope  after  the  peak.  These  data  empha-
ize  the  need  to  pay  much  attention  to  the  ROI  position,
nd  to  be  very  careful  if  the  washout  ratio  is  barely  30%
n  the  time—intensity  curve.  We  think  that  the  slope  after
he  peak  is  an  important  data:  Warthin’s  tumors,  in  our  study
nd  in  Yabuuchi  study,  presented  after  the  peak  a  high  nega-
ive  slope  which  was  not  present  in  these  two  cases.  Further
tudies  should  focus  on  this.
The  sensitivity  of  this  technique  for  the  diagnosis  of
arthin’s  tumor  was  found  to  be  80—85%.  That  means  that
oth  readers  did  not  identify  all  the  Warthin’s  tumors  with
his  algorithm.  These  patients  would  have  undergone  non-
seful  surgery,  but  that  is  the  most  common  management  to
ate.  As  far  as  we  know,  this  MR  imaging  sensitivity  value  for
he  diagnosis  of  Warthin’s  tumors  is  not  reported  in  the  lit-
rature  since  all  studies,  excepted  Ikeda’s  study  [15],  have
ooled  pleomorphic  adenomas  and  Warthin’s  tumors  into  a
lobal  benign  tumor  group.  Ikeda  et  al.  [15]  did  not  pool
arthin’s  tumor  and  pleomorphic  adenomas,  but  they  only
eported  average  ADC  values  and  washout  ratios,  without
iving  us  neither  threshold  values  nor  speciﬁcity  values.
The  accuracy  of  our  technique  was  found  to  be  92—96%.
his  value  is  higher  than  the  accuracy  value  of  FNAC,  which
s  reported  to  be  74—81%  [22,23]. Hence,  the  risk  of  not  per-
orming  a  necessary  surgical  treatment  after  MRI  is  similar
o  the  risk  of  error  of  FNAC  [24].
Furthermore,  in  Warhtin’s  tumors,  FNAC  may  induce
arotiditis,  without  any  relation  to  infection  [14]. That  is
hy,  according  to  Suzuki  et  al.  [14], we  think  that  it  may
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e  better  to  avoid  systematic  FNAC  when  faced  to  a lesion
trongly  suspected  to  be  a  Warthin’s  tumor  after  a  complete
R  imaging  interpreted  with  our  algorithm.
Our  study  had  some  limitations.  Firstly,  we  had  only  20
arthin’s  tumors;  but  this  prevalence  is  similar  to  what
s  reported  in  literature  [25].  Secondly,  only  7  Warthin’s
umors  were  histologically  proved,  the  13  remaining  only
nderwent  FNAC  and  at  least  one-year  MRI  follow-up.  But,
he  FNAC  diagnosis  of  Warthin’s  tumor  is  reliable  [24]  and
hen  coupled  with  appropriate  clinical  ﬁndings  and  one-
ear  follow-up,  the  accuracy  is  very  high  [23,24].  Thirdly,
e  excluded  tumors  with  no  diffusion  or  perfusion  workable
ata;  it  means  that  mainly  cystic  lesions  and  lesions  less  than
0  mm  in  diameter  were  all  excluded  because  it  was  impos-
ible  to  place  a  ROI  on  a  tissular  part.  Warthin’s  tumors  can
resent  as  cystic  lesions.  So  our  results  are  not  useful  for
ll  parotid  gland  tumors  but  only  for  supra  centimetric  non-
ystic  lesions.  In  our  study,  these  both  categories  of  tumors
epresented  6.2%  of  the  lesions  (n  =  5/80).  Fourthly,  we  used
he  ADC  ratio  between  the  tumor  and  the  contralateral  nor-
al  gland,  with  our  experimentally  pre-established  cut-off
alues.  The  ADC  value  of  the  normal  gland  can  be  modiﬁed
y  many  factors,  such  as  fat  involution  or  acid  consump-
ion  before  the  MR  examination.  But  using  the  absolute  ADC
alue,  the  results  might  be  dependent  on  technical  factors
nd  might  not  be  transferable  to  other  institutions.  Finally,
he  DCE  sequence  lasted  for  only  3  min,  while  in  Yabuuchi
tudy  the  cut-off  value  of  30%  was  deﬁned  after  5  min.  But
n  our  study  the  delay  before  the  signal  increase  was  only
0  s  while  in  Yabuuchi  study  it  was  60  s.  It  means  that  the
ifference  was  80  s  at  the  end  of  the  sequence  when  the
ignal  intensity  decrease  rate  was  very  low,  in  both  studies.
e  think  that  further  studies  should  focus  on  the  optimum
elay  for  the  calculation  of  the  washout  ratio,  because  some
alignant  lesions,  with  low  signal  intensity  decrease,  could
resent  a  washout  ratio  less  than  30%  3  min  after  the  con-
rast  injection  and  more  than  30%  5  min  after  the  contrast
njection.  This  may  partially  explain  the  very  low  number  of
alse  positive  of  Warthin’s  tumors  in  our  study.
However,  to  our  knowledge,  this  is  the  ﬁrst  report  about
he  diagnostic  value  of  a  decisional  algorithm,  with  func-
ional  MRI,  for  the  diagnosis  of  Warthin’s  tumors.
onclusion
n  conclusion,  our  algorithm  helps  the  diagnosis  of  Warhtin’s
umor  with  MR  imaging.  The  speciﬁcity  of  the  technique  is
ufﬁcient  to  avoid  surgery  when  the  parotid  gland  tumor
resents  all  the  MR  characteristics  of  a  Warthin’s  tumor.
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